American Well Corporation (AMWL)
USD 7.41
(19.71%)
USD 7.41
(19.71%)
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2023 | -675.16 Million USD | -150.25% |
| 2022 | -269.79 Million USD | -55.37% |
| 2021 | -173.65 Million USD | 23.31% |
| 2020 | -226.43 Million USD | -156.25% |
| 2019 | -88.36 Million USD | -67.76% |
| 2018 | -52.67 Million USD | 0.0% |
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2024 Q2 | -49.92 Million USD | 30.77% |
| 2024 Q3 | -43.46 Million USD | 12.93% |
| 2024 Q1 | -72.1 Million USD | -48.4% |
| 2023 Q3 | -136.41 Million USD | -47.51% |
| 2023 FY | -675.16 Million USD | -150.25% |
| 2023 Q1 | -397.85 Million USD | -555.78% |
| 2023 Q2 | -92.47 Million USD | 76.76% |
| 2023 Q4 | -48.58 Million USD | 64.38% |
| 2022 Q2 | -69.1 Million USD | 1.34% |
| 2022 Q1 | -70.04 Million USD | -46.55% |
| 2022 Q3 | -69.98 Million USD | -1.27% |
| 2022 Q4 | -60.66 Million USD | 13.31% |
| 2022 FY | -269.79 Million USD | -55.37% |
| 2021 Q2 | -37.85 Million USD | 3.39% |
| 2021 Q4 | -47.79 Million USD | 7.19% |
| 2021 Q3 | -51.49 Million USD | -36.02% |
| 2021 FY | -173.65 Million USD | 23.31% |
| 2021 Q1 | -39.18 Million USD | 22.11% |
| 2020 FY | -226.43 Million USD | -156.25% |
| 2020 Q4 | -50.31 Million USD | 20.24% |
| 2020 Q3 | -63.08 Million USD | 27.21% |
| 2020 Q2 | -86.65 Million USD | -255.43% |
| 2020 Q1 | -24.38 Million USD | -8.69% |
| 2019 FY | -88.36 Million USD | -67.76% |
| 2019 Q4 | -22.43 Million USD | 6.6% |
| 2019 Q3 | -24.01 Million USD | -22.44% |
| 2019 Q2 | -19.61 Million USD | 7.18% |
| 2019 Q1 | -21.13 Million USD | 0.0% |
| 2018 FY | -52.67 Million USD | 0.0% |
| Name | Net Income | Net Income Difference |
|---|---|---|
| Doximity, Inc. | 147.58 Million USD | 557.484% |
| Evolent Health, Inc. | -113.04 Million USD | -497.279% |
| MultiPlan Corporation | -91.69 Million USD | -636.299% |
| Phreesia, Inc. | -136.88 Million USD | -393.234% |
| Teladoc Health, Inc. | -220.36 Million USD | -206.38% |
| Veeva Systems Inc. | 525.7 Million USD | 228.43% |